Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
30.7M
-
Shares change
-
+404K
-
Total reported value, excl. options
-
$6.46M
-
Value change
-
+$54.6K
-
Put/Call ratio
-
0.26
-
Number of buys
-
11
-
Number of sells
-
-18
-
Price
-
$0.21
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q1 2025
46 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q1 2025.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.7M shares
.
Largest 10 shareholders include BVF INC/IL (9.54M shares), Logos Global Management LP (5.4M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (5.09M shares), VR ADVISER, LLC (3M shares), VANGUARD GROUP INC (2.67M shares), WELLINGTON MANAGEMENT GROUP LLP (1.37M shares), BlackRock, Inc. (726K shares), Jefferies Financial Group Inc. (585K shares), GEODE CAPITAL MANAGEMENT, LLC (572K shares), and UBS Group AG (466K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.